{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T14:20:46Z","timestamp":1768832446026,"version":"3.49.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2021,4,21]],"date-time":"2021-04-21T00:00:00Z","timestamp":1618963200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,4,21]],"date-time":"2021-04-21T00:00:00Z","timestamp":1618963200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81970837"],"award-info":[{"award-number":["81970837"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Genet Genomics"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1007\/s00438-021-01783-0","type":"journal-article","created":{"date-parts":[[2021,4,21]],"date-time":"2021-04-21T19:15:50Z","timestamp":1619032550000},"page":"845-862","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Pathogenicity evaluation and the genotype\u2013phenotype analysis of OPA1 variants"],"prefix":"10.1007","volume":"296","author":[{"given":"Xingyu","family":"Xu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Panfeng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoyun","family":"Jia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenmin","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shiqiang","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xueshan","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. Fielding","family":"Hejtmancik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7508-848X","authenticated-orcid":false,"given":"Qingjiong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,4,21]]},"reference":[{"key":"1783_CR1","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1038\/79944","volume":"26","author":"C Alexander","year":"2000","unstructured":"Alexander C, Votruba M, Pesch UE, Thiselton DL, Mayer S, Moore A, Rodriguez M, Kellner U, Leo-Kottler B, Auburger G, Bhattacharya SS, Wissinger B (2000) OPA1, encoding a dynamin-related GTPase, is mutated in autosomal dominant optic atrophy linked to chromosome 3q28. Nat Genet 26:211\u2013215","journal-title":"Nat Genet"},{"key":"1783_CR2","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1186\/1471-2350-13-65","volume":"13","author":"GJ Almind","year":"2012","unstructured":"Almind GJ, Ek J, Rosenberg T, Eiberg H, Larsen M, Lucamp L, Brondum-Nielsen K, Gronskov K (2012) Dominant optic atrophy in Denmark\u2014report of 15 novel mutations in OPA1, using a strategy with a detection rate of 90%. BMC Med Genet 13:65","journal-title":"BMC Med Genet"},{"key":"1783_CR3","doi-asserted-by":"publisher","first-page":"1855","DOI":"10.1016\/j.biocel.2009.04.012","volume":"41","author":"P Amati-Bonneau","year":"2009","unstructured":"Amati-Bonneau P, Milea D, Bonneau D, Chevrollier A, Ferre M, Guillet V, Gueguen N, Loiseau D, de Crescenzo MA, Verny C, Procaccio V, Lenaers G, Reynier P (2009) OPA1-associated disorders: phenotypes and pathophysiology. Int J Biochem Cell Biol 41:1855\u20131865","journal-title":"Int J Biochem Cell Biol"},{"key":"1783_CR4","doi-asserted-by":"publisher","first-page":"2164","DOI":"10.1093\/brain\/awu165","volume":"137","author":"T Bonifert","year":"2014","unstructured":"Bonifert T, Karle KN, Tonagel F, Batra M, Wilhelm C, Theurer Y, Schoenfeld C, Kluba T, Kamenisch Y, Carelli V, Wolf J, Gonzalez MA, Speziani F, Schule R, Zuchner S, Schols L, Wissinger B, Synofzik M (2014) Pure and syndromic optic atrophy explained by deep intronic OPA1 mutations and an intralocus modifier. Brain 137:2164\u20132177","journal-title":"Brain"},{"key":"1783_CR5","doi-asserted-by":"publisher","first-page":"e321","DOI":"10.1093\/brain\/awu234","volume":"138","author":"V Carelli","year":"2015","unstructured":"Carelli V, Sabatelli M, Carrozzo R, Rizza T, Schimpf S, Wissinger B, Zanna C, Rugolo M, La Morgia C, Caporali L, Carbonelli M, Barboni P, Tonon C, Lodi R, Bertini E (2015) \u2018Behr syndrome\u2019 with OPA1 compound heterozygote mutations. Brain 138:e321","journal-title":"Brain"},{"key":"1783_CR6","first-page":"292","volume":"19","author":"Y Chen","year":"2013","unstructured":"Chen Y, Jia X, Wang P, Xiao X, Li S, Guo X, Zhang Q (2013) Mutation survey of the optic atrophy 1 gene in 193 Chinese families with suspected hereditary optic neuropathy. Mol Vis 19:292\u2013302","journal-title":"Mol Vis"},{"key":"1783_CR7","doi-asserted-by":"publisher","first-page":"6987","DOI":"10.1167\/iovs.14-14953","volume":"55","author":"J Chen","year":"2014","unstructured":"Chen J, Xu K, Zhang X, Jiang F, Liu L, Dong B, Ren Y, Li Y (2014) Mutation screening of mitochondrial DNA as well as OPA1 and OPA3 in a Chinese cohort with suspected hereditary optic atrophy. Investig Ophthalmol Vis Sci 55:6987\u20136995","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"1783_CR8","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1016\/j.ajo.2006.12.038","volume":"143","author":"AC Cohn","year":"2007","unstructured":"Cohn AC, Toomes C, Potter C, Towns KV, Hewitt AW, Inglehearn CF, Craig JE, Mackey DA (2007) Autosomal dominant optic atrophy: penetrance and expressivity in patients with OPA1 mutations. Am J Ophthalmol 143:656\u2013662","journal-title":"Am J Ophthalmol"},{"key":"1783_CR9","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1002\/ana.21376","volume":"63","author":"K Cornille","year":"2008","unstructured":"Cornille K, Milea D, Amati-Bonneau P, Procaccio V, Zazoun L, Guillet V, El Achouri G, Delettre C, Gueguen N, Loiseau D, Muller A, Ferre M, Chevrollier A, Wallace DC, Bonneau D, Hamel C, Reynier P, Lenaers G (2008) Reversible optic neuropathy with OPA1 exon 5b mutation. Ann Neurol 63:667\u2013671","journal-title":"Ann Neurol"},{"key":"1783_CR10","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1016\/j.exer.2006.03.004","volume":"83","author":"S Dadgar","year":"2006","unstructured":"Dadgar S, Hagens O, Dadgar SR, Haghighi EN, Schimpf S, Wissinger B, Garshasbi M (2006) Structural model of the OPA1 GTPase domain may explain the molecular consequences of a novel mutation in a family with autosomal dominant optic atrophy. Exp Eye Res 83:702\u2013706","journal-title":"Exp Eye Res"},{"key":"1783_CR11","doi-asserted-by":"publisher","first-page":"2557","DOI":"10.1016\/j.celrep.2017.05.073","volume":"19","author":"V Del Dotto","year":"2017","unstructured":"Del Dotto V, Mishra P, Vidoni S, Fogazza M, Maresca A, Caporali L, McCaffery JM, Cappelletti M, Baruffini E, Lenaers G, Chan D, Rugolo M, Carelli V, Zanna C (2017) OPA1 isoforms in the hierarchical organization of mitochondrial functions. Cell Rep 19:2557\u20132571","journal-title":"Cell Rep"},{"key":"1783_CR12","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1038\/79936","volume":"26","author":"C Delettre","year":"2000","unstructured":"Delettre C, Lenaers G, Griffoin JM, Gigarel N, Lorenzo C, Belenguer P, Pelloquin L, Grosgeorge J, Turc-Carel C, Perret E, Astarie-Dequeker C, Lasquellec L, Arnaud B, Ducommun B, Kaplan J, Hamel CP (2000) Nuclear gene OPA1, encoding a mitochondrial dynamin-related protein, is mutated in dominant optic atrophy. Nat Genet 26:207\u2013210","journal-title":"Nat Genet"},{"key":"1783_CR13","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1007\/s00439-001-0633-y","volume":"109","author":"C Delettre","year":"2001","unstructured":"Delettre C, Griffoin JM, Kaplan J, Dollfus H, Lorenz B, Faivre L, Lenaers G, Belenguer P, Hamel CP (2001) Mutation spectrum and splicing variants in the OPA1 gene. Hum Genet 109:584\u2013591","journal-title":"Hum Genet"},{"key":"1783_CR14","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1002\/humu.22981","volume":"37","author":"JT den Dunnen","year":"2016","unstructured":"den Dunnen JT, Dalgleish R, Maglott DR, Hart RK, Greenblatt MS, McGowan-Jordan J, Roux AF, Smith T, Antonarakis SE, Taschner PE (2016) HGVS recommendations for the description of sequence variants: 2016 update. Hum Mutat 37:564\u2013569","journal-title":"Hum Mutat"},{"key":"1783_CR15","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/B978-0-12-801415-8.00016-3","volume":"547","author":"AS Divakaruni","year":"2014","unstructured":"Divakaruni AS, Paradyse A, Ferrick DA, Murphy AN, Jastroch M (2014) Analysis and interpretation of microplate-based oxygen consumption and pH data. Methods Enzymol 547:309\u2013354","journal-title":"Methods Enzymol"},{"key":"1783_CR16","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1007\/s002040000173","volume":"74","author":"A Dorrenhaus","year":"2000","unstructured":"Dorrenhaus A, Muller JI, Golka K, Jedrusik P, Schulze H, Follmann W (2000) Cultures of exfoliated epithelial cells from different locations of the human urinary tract and the renal tubular system. Arch Toxicol 74:618\u2013626","journal-title":"Arch Toxicol"},{"key":"1783_CR17","doi-asserted-by":"publisher","first-page":"E692","DOI":"10.1002\/humu.21025","volume":"30","author":"M Ferre","year":"2009","unstructured":"Ferre M, Bonneau D, Milea D, Chevrollier A, Verny C, Dollfus H, Ayuso C, Defoort S, Vignal C, Zanlonghi X, Charlin JF, Kaplan J, Odent S, Hamel CP, Procaccio V, Reynier P, Amati-Bonneau P (2009) Molecular screening of 980 cases of suspected hereditary optic neuropathy with a report on 77 novel OPA1 mutations. Hum Mutat 30:E692-705","journal-title":"Hum Mutat"},{"key":"1783_CR18","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1002\/humu.21438","volume":"32","author":"IF Fokkema","year":"2011","unstructured":"Fokkema IF, Taschner PE, Schaafsma GC, Celli J, Laros JF, den Dunnen JT (2011) LOVD vol 2.0: the next generation in gene variant databases. Hum Mutat 32:557\u2013563","journal-title":"Hum Mutat"},{"key":"1783_CR19","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.cell.2006.06.025","volume":"126","author":"C Frezza","year":"2006","unstructured":"Frezza C, Cipolat S, Martins de Brito O, Micaroni M, Beznoussenko GV, Rudka T, Bartoli D, Polishuck RS, Danial NN, De Strooper B, Scorrano L (2006) OPA1 controls apoptotic cristae remodeling independently from mitochondrial fusion. Cell 126:177\u2013189","journal-title":"Cell"},{"key":"1783_CR20","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1093\/nar\/gkw010","volume":"44","author":"N Hug","year":"2016","unstructured":"Hug N, Longman D, Caceres JF (2016) Mechanism and regulation of the nonsense-mediated decay pathway. Nucleic Acids Res 44:1483\u20131495","journal-title":"Nucleic Acids Res"},{"key":"1783_CR21","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1167\/iovs.14-14850","volume":"56","author":"D Jiang","year":"2014","unstructured":"Jiang D, Li J, Xiao X, Li S, Jia X, Sun W, Guo X, Zhang Q (2014) Detection of mutations in LRPAP1, CTSH, LEPREL1, ZNF644, SLC39A5, and SCO2 in 298 families with early-onset high myopia by exome sequencing. Investig Ophthalmol Vis Sci 56:339\u2013345","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"1783_CR22","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1186\/s13023-019-1187-1","volume":"14","author":"B Le Roux","year":"2019","unstructured":"Le Roux B, Lenaers G, Zanlonghi X, Amati-Bonneau P, Chabrun F, Foulonneau T, Caignard A, Leruez S, Gohier P, Procaccio V, Milea D, den Dunnen JT, Reynier P, Ferr\u00e9 M (2019) OPA1: 516 unique variants and 831 patients registered in an updated centralized Variome database. Orphanet J Rare Dis 14:214","journal-title":"Orphanet J Rare Dis"},{"key":"1783_CR23","doi-asserted-by":"publisher","first-page":"33","DOI":"10.3892\/mmr.2016.5209","volume":"14","author":"J Lee","year":"2016","unstructured":"Lee J, Jung SC, Hong YB, Yoo JH, Koo H, Lee JH, Hong HD, Kim SB, Chung KW, Choi BO (2016) Recessive optic atrophy, sensorimotor neuropathy and cataract associated with novel compound heterozygous mutations in OPA1. Mol Med Rep 14:33\u201340","journal-title":"Mol Med Rep"},{"key":"1783_CR24","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.ceb.2005.03.002","volume":"17","author":"F Lejeune","year":"2005","unstructured":"Lejeune F, Maquat LE (2005) Mechanistic links between nonsense-mediated mRNA decay and pre-mRNA splicing in mammalian cells. Curr Opin Cell Biol 17:309\u2013315","journal-title":"Curr Opin Cell Biol"},{"key":"1783_CR25","doi-asserted-by":"publisher","first-page":"e0170090","DOI":"10.1371\/journal.pone.0170090","volume":"12","author":"Y Li","year":"2017","unstructured":"Li Y, Li J, Jia X, Xiao X, Li S, Guo X (2017) Genetic and clinical analyses of DOA and LHON in 304 Chinese patients with suspected childhood-onset hereditary optic neuropathy. PLoS ONE 12:e0170090","journal-title":"PLoS ONE"},{"key":"1783_CR26","first-page":"e181","volume":"98","author":"S Li","year":"2020","unstructured":"Li S, Xiao X, Yi Z, Sun W, Wang P, Zhang Q (2020) RPE65 mutation frequency and phenotypic variation according to exome sequencing in a tertiary centre for genetic eye diseases in China. Acta Ophthalmol 98:e181\u2013e190","journal-title":"Acta Ophthalmol"},{"key":"1783_CR27","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1212\/WNL.0000000000003491","volume":"88","author":"C Liao","year":"2017","unstructured":"Liao C, Ashley N, Diot A, Morten K, Phadwal K, Williams A, Fearnley I, Rosser L, Lowndes J, Fratter C, Ferguson DJ, Vay L, Quaghebeur G, Moroni I, Bianchi S, Lamperti C, Downes SM, Sitarz KS, Flannery PJ, Carver J, Dombi E, East D, Laura M, Reilly MM, Mortiboys H, Prevo R, Campanella M, Daniels MJ, Zeviani M, Yu-Wai-Man P, Simon AK, Votruba M, Poulton J (2017) Dysregulated mitophagy and mitochondrial organization in optic atrophy due to OPA1 mutations. Neurology 88:131\u2013142","journal-title":"Neurology"},{"key":"1783_CR28","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1038\/ncb3565","volume":"19","author":"R Liu","year":"2017","unstructured":"Liu R, Chan DC (2017) OPA1 and cardiolipin team up for mitochondrial fusion. Nat Cell Biol 19:760\u2013762","journal-title":"Nat Cell Biol"},{"key":"1783_CR29","doi-asserted-by":"publisher","first-page":"7629","DOI":"10.1167\/iovs.15-17951","volume":"56","author":"EK Morny","year":"2015","unstructured":"Morny EK, Margrain TH, Binns AM, Votruba M (2015) Electrophysiological ON and OFF responses in autosomal dominant optic atrophy. Investig Ophthalmol Vis Sci 56:7629\u20137637","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"1783_CR30","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1186\/s13023-017-0641-1","volume":"12","author":"A Nasca","year":"2017","unstructured":"Nasca A, Rizza T, Doimo M, Legati A, Ciolfi A, Diodato D, Calderan C, Carrara G, Lamantea E, Aiello C, Di Nottia M, Niceta M, Lamperti C, Ardissone A, Bianchi-Marzoli S, Iarossi G, Bertini E, Moroni I, Tartaglia M, Salviati L, Carrozzo R, Ghezzi D (2017) Not only dominant, not only optic atrophy: expanding the clinical spectrum associated with OPA1 mutations. Orphanet J Rare Dis 12:89","journal-title":"Orphanet J Rare Dis"},{"key":"1783_CR31","first-page":"598","volume":"15","author":"Y Nochez","year":"2009","unstructured":"Nochez Y, Arsene S, Gueguen N, Chevrollier A, Ferre M, Guillet V, Desquiret V, Toutain A, Bonneau D, Procaccio V, Amati-Bonneau P, Pisella PJ, Reynier P (2009) Acute and late-onset optic atrophy due to a novel OPA1 mutation leading to a mitochondrial coupling defect. Mol Vis 15:598\u2013608","journal-title":"Mol Vis"},{"key":"1783_CR32","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/S0014-5793(02)02985-X","volume":"523","author":"A Olichon","year":"2002","unstructured":"Olichon A, Emorine LJ, Descoins E, Pelloquin L, Brichese L, Gas N, Guillou E, Delettre C, Valette A, Hamel CP, Ducommun B, Lenaers G, Belenguer P (2002) The human dynamin-related protein OPA1 is anchored to the mitochondrial inner membrane facing the inter-membrane space. FEBS Lett 523:171\u2013176","journal-title":"FEBS Lett"},{"key":"1783_CR33","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1093\/hmg\/10.13.1359","volume":"10","author":"UE Pesch","year":"2001","unstructured":"Pesch UE, Leo-Kottler B, Mayer S, Jurklies B, Kellner U, Apfelstedt-Sylla E, Zrenner E, Alexander C, Wissinger B (2001) OPA1 mutations in patients with autosomal dominant optic atrophy and evidence for semi-dominant inheritance. Hum Mol Genet 10:1359\u20131368","journal-title":"Hum Mol Genet"},{"key":"1783_CR34","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","volume":"17","author":"S Richards","year":"2015","unstructured":"Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, Grody WW, Hegde M, Lyon E, Spector E, Voelkerding K, Rehm HL (2015) Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med 17:405\u2013424","journal-title":"Genet Med"},{"key":"1783_CR35","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1016\/j.ejpn.2017.04.004","volume":"21","author":"A Rubegni","year":"2017","unstructured":"Rubegni A, Pisano T, Bacci G, Tessa A, Battini R, Procopio E, Giglio S, Pasquariello R, Santorelli FM, Guerrini R, Nesti C (2017) Leigh-like neuroimaging features associated with new biallelic mutations in OPA1. Eur J Paediatr Neurol 21:671\u2013677","journal-title":"Eur J Paediatr Neurol"},{"key":"1783_CR36","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1002\/humu.20607","volume":"29","author":"S Schimpf","year":"2008","unstructured":"Schimpf S, Fuhrmann N, Schaich S, Wissinger B (2008) Comprehensive cDNA study and quantitative transcript analysis of mutant OPA1 transcripts containing premature termination codons. Hum Mutat 29:106\u2013112","journal-title":"Hum Mutat"},{"key":"1783_CR37","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1136\/jmedgenet-2015-103361","volume":"53","author":"R Spiegel","year":"2016","unstructured":"Spiegel R, Saada A, Flannery PJ, Burte F, Soiferman D, Khayat M, Eisner V, Vladovski E, Taylor RW, Bindoff LA, Shaag A, Mandel H, Schuler-Furman O, Shalev SA, Elpeleg O, Yu-Wai-Man P (2016) Fatal infantile mitochondrial encephalomyopathy, hypertrophic cardiomyopathy and optic atrophy associated with a homozygous OPA1 mutation. J Med Genet 53:127\u2013131","journal-title":"J Med Genet"},{"key":"1783_CR38","doi-asserted-by":"publisher","first-page":"8365","DOI":"10.1167\/iovs.15-17555","volume":"56","author":"W Sun","year":"2015","unstructured":"Sun W, Huang L, Xu Y, Xiao X, Li S, Jia X, Gao B, Wang P, Guo X, Zhang Q (2015) Exome sequencing on 298 probands with early-onset high myopia: approximately one-fourth show potential pathogenic mutations in RetNet genes. Investig Ophthalmol Vis Sci 56:8365\u20138372","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"1783_CR39","first-page":"1715","volume":"43","author":"DL Thiselton","year":"2002","unstructured":"Thiselton DL, Alexander C, Taanman JW, Brooks S, Rosenberg T, Eiberg H, Andreasson S, Van Regemorter N, Munier FL, Moore AT, Bhattacharya SS, Votruba M (2002) A comprehensive survey of mutations in the OPA1 gene in patients with autosomal dominant optic atrophy. Investig Ophthalmol Vis Sci 43:1715\u20131724","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"1783_CR40","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1016\/j.cmet.2015.05.007","volume":"21","author":"T Varanita","year":"2015","unstructured":"Varanita T, Soriano ME, Romanello V, Zaglia T, Quintana-Cabrera R, Semenzato M, Menabo R, Costa V, Civiletto G, Pesce P, Viscomi C, Zeviani M, Di Lisa F, Mongillo M, Sandri M, Scorrano L (2015) The OPA1-dependent mitochondrial cristae remodeling pathway controls atrophic, apoptotic, and ischemic tissue damage. Cell Metab 21:834\u2013844","journal-title":"Cell Metab"},{"key":"1783_CR41","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1167\/tvst.8.2.21","volume":"8","author":"P Wang","year":"2019","unstructured":"Wang P, Li S, Sun W, Xiao X, Jia X, Liu M, Xu L, Long Y, Zhang Q (2019) An ophthalmic targeted exome sequencing panel as a powerful tool to identify causative mutations in patients suspected of hereditary eye diseases. Transl Vis Sci Technol 8:21","journal-title":"Transl Vis Sci Technol"},{"key":"1783_CR42","first-page":"477","volume":"21","author":"Y Xu","year":"2015","unstructured":"Xu Y, Guan L, Xiao X, Zhang J, Li S, Jiang H, Jia X, Yang J, Guo X, Yin Y, Wang J, Zhang Q (2015) Mutation analysis in 129 genes associated with other forms of retinal dystrophy in 157 families with retinitis pigmentosa based on exome sequencing. Mol Vis 21:477\u2013486","journal-title":"Mol Vis"},{"key":"1783_CR43","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.exer.2016.06.019","volume":"149","author":"Y Xu","year":"2016","unstructured":"Xu Y, Xiao X, Li S, Jia X, Xin W, Wang P, Sun W, Huang L, Guo X, Zhang Q (2016) Molecular genetics of Leber congenital amaurosis in Chinese: new data from 66 probands and mutation overview of 159 probands. Exp Eye Res 149:93\u201399","journal-title":"Exp Eye Res"},{"key":"1783_CR44","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1016\/S0008-4182(06)80034-7","volume":"41","author":"S Yoshida","year":"2006","unstructured":"Yoshida S, Yamaji Y, Yoshida A, Kuwahara R, Fujisawa K, Ishibashi T (2006) Prognostic DNA testing and counselling for dominant optic atrophy due to a novel OPA1 mutation. Can J Ophthalmol 41:614\u2013616","journal-title":"Can J Ophthalmol"},{"issue":"1538\u20131546","key":"1783_CR45","first-page":"1546.e1531","volume":"117","author":"P Yu-Wai-Man","year":"2010","unstructured":"Yu-Wai-Man P, Griffiths PG, Burke A, Sellar PW, Clarke MP, Gnanaraj L, Ah-Kine D, Hudson G, Czermin B, Taylor RW, Horvath R, Chinnery PF (2010a) The prevalence and natural history of dominant optic atrophy due to OPA1 mutations. Ophthalmology 117(1538\u20131546):1546.e1531","journal-title":"Ophthalmology"},{"key":"1783_CR46","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1093\/brain\/awq007","volume":"133","author":"P Yu-Wai-Man","year":"2010","unstructured":"Yu-Wai-Man P, Griffiths PG, Gorman GS, Lourenco CM, Wright AF, Auer-Grumbach M, Toscano A, Musumeci O, Valentino ML, Caporali L, Lamperti C, Tallaksen CM, Duffey P, Miller J, Whittaker RG, Baker MR, Jackson MJ, Clarke MP, Dhillon B, Czermin B, Stewart JD, Hudson G, Reynier P, Bonneau D, Marques W Jr, Lenaers G, McFarland R, Taylor RW, Turnbull DM, Votruba M, Zeviani M, Carelli V, Bindoff LA, Horvath R, Amati-Bonneau P, Chinnery PF (2010b) Multi-system neurological disease is common in patients with OPA1 mutations. Brain 133:771\u2013786","journal-title":"Brain"},{"key":"1783_CR47","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1093\/brain\/awm335","volume":"131","author":"C Zanna","year":"2008","unstructured":"Zanna C, Ghelli A, Porcelli AM, Karbowski M, Youle RJ, Schimpf S, Wissinger B, Pinti M, Cossarizza A, Vidoni S, Valentino ML, Rugolo M, Carelli V (2008) OPA1 mutations associated with dominant optic atrophy impair oxidative phosphorylation and mitochondrial fusion. Brain 131:352\u2013367","journal-title":"Brain"},{"key":"1783_CR48","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1007\/s11011-019-00415-2","volume":"34","author":"A Zerem","year":"2019","unstructured":"Zerem A, Yosovich K, Rappaport YC, Libzon S, Blumkin L, Ben-Sira L, Lev D, Lerman-Sagie T (2019) Metabolic stroke in a patient with bi-allelic OPA1 mutations. Metab Brain Dis 34:1043\u20131048","journal-title":"Metab Brain Dis"},{"key":"1783_CR49","doi-asserted-by":"publisher","first-page":"1622","DOI":"10.1007\/s12035-016-9771-z","volume":"54","author":"AM Zhang","year":"2017","unstructured":"Zhang AM, Bi R, Hu QX, Fan Y, Zhang Q, Yao YG (2017) The OPA1 gene mutations are frequent in Han Chinese patients with suspected optic neuropathy. Mol Neurobiol 54:1622\u20131630","journal-title":"Mol Neurobiol"},{"key":"1783_CR50","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.exer.2018.02.007","volume":"171","author":"L Zhou","year":"2018","unstructured":"Zhou L, Xiao X, Li S, Jia X, Zhang Q (2018) Frequent mutations of RetNet genes in eoHM: further confirmation in 325 probands and comparison with late-onset high myopia based on exome sequencing. Exp Eye Res 171:76\u201391","journal-title":"Exp Eye Res"}],"container-title":["Molecular Genetics and Genomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00438-021-01783-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00438-021-01783-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00438-021-01783-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,22]],"date-time":"2021-07-22T16:14:07Z","timestamp":1626970447000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00438-021-01783-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,21]]},"references-count":50,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,7]]}},"alternative-id":["1783"],"URL":"https:\/\/doi.org\/10.1007\/s00438-021-01783-0","relation":{},"ISSN":["1617-4615","1617-4623"],"issn-type":[{"value":"1617-4615","type":"print"},{"value":"1617-4623","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,21]]},"assertion":[{"value":"10 October 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 April 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 April 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures in this study conformed to the tenets of the Helsinki Declaration, and was approved by the ZOC institutional review board.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all participants or their guardians prior to the collection of clinical data, venous blood and urine samples.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}